Directorate Change
Chief Scientific Officer Dr Ian Pike steps down to Non-Executive Director role, providing consultancy services.
Select text to share a quote on X · sign in to keep highlights & notes in your PRM notes
The directors of Proteome Sciences plc announce that Dr Ian Pike has decided to step down from his executive role as Chief Scientific Officer with effect from 31 May 2026. To maintain continuity, Dr Pike will assume a Non-Executive Director position on the same date, whereby he has committed to provide consultancy services as required to cover his former responsibilities at Proteome Sciences. In this way the business will continue to benefit from Dr Pike's considerable expertise and industry knowledge, whilst allowing him a better time-balance for his personal life.
Proteome Sciences plc
| Christopher Pearce, Executive Chairman | Tel: +44 (0) 20 7043 2116 |
| Richard Dennis, Chief Commercial Officer | |
| SP Angel Corporate Finance LLP (Nominated Adviser & Broker) | |
| David Hignell/Matthew Johnson/Josh Ray (Corporate Finance) Vadim Alexandre (Corporate Broking) | Tel: +44 (0) 20 3470 0470 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.